{"nct_id":"NCT02157298","title":"Phase IV Study With a 36-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin Therapy When Added to the Therapy of Japanese Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin.","status":"COMPLETED","status_verified_date":"2016-03","start_date":"2014-06","start_date_type":null,"primary_completion_date":"2015-02","primary_completion_date_type":"ACTUAL","completion_date":"2015-11","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["AZN"]}